Profile
| Metric | Value |
|---|---|
| Full Name | Mind Medicine (MindMed) Inc. |
| Ticker | NASDAQ: MNMD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mindmed.co |
| Employees | 74 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.03 | |
| Price, 1D Change | +3.85% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.66 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.54 | |
| EPS, 1Y Change | +36.91% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.54 | |
| EPS Estimate | -$2.02 | |
| EPS Est. Change | -31.22% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $14.03 | |
| Price Target | - | $24.50 |
| Price Tgt. Change | - | +74.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.27 | -$2.44 | -7.70% | |
| -$1.48 | -$1.54 | -4.01% | |
| -$2.02 | N/A | -31.22% | |
| -$1.77 | N/A | -14.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +73.00% | |
| Price, 3Y | +431.44% | |
| Market Cap, 1Y | +126.92% | |
| Market Cap, 3Y | +1,278.44% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +36.91% | |
| EPS, 3Y | +54.61% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.03 | |
| SMA 200 | $9.45 | |
| SMA 200 vs Price | -32.64% | |
| SMA 50 | $12.44 | |
| SMA 50 vs Price | -11.31% | |
| Beta | 1.66 | |
| ATR | $0.79 | |
| 14-Day RSI | 62.09 | |
| 10-Day Volatility | 54.28% | |
| 1-Year Volatility | 73.97% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.54 | |
| Gross Profit | -$527.00K | |
| Gross Margin | - | |
| Operating Profit | -$103.92M | |
| Operating Margin | - | |
| Net Income | -$108.68M | |
| Net Margin | - | |
| EBITDA | -$103.39M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.09 | |
| Current Ratio | 7.25 | |
| Quick Ratio | 7.25 | |
| - | ||
| F-Score | - | |
| Altman Z-Score | 11.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 10.58 | |
| EV/EBITDA | -8.03 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $241.45M | |
| Cash & Equivalents | $273.74M | |
| Total Assets | $302.15M | |
| Current Assets | $281.62M | |
| Total Liabilities | $60.70M | |
| Current Liabilities | $38.85M | |
| Total Debt | $21.85M | |
| Short Term Debt | $0.00 | |
| Accounts Payable | $2.01M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $108.68M | |
| Operating Expenses | $103.39M | |
| Cost Of Goods Sold | $527.00K | |
| SG&A | $0.00 | |
| D&A | $527.00K | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$79.13M | |
| CFI | $0.00 | |
| CFF | $253.20M | |
| Capex | $0.00 | |
| Free Cash Flow | -$79.13M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with MNMD
Data Sources & References
- MNMD Official Website www.mindmed.co
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1813814/000119312525269596/0001193125-25-269596-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1813814/000095017025034176/0000950170-25-034176-index.htm
- MNMD Profile on Yahoo Finance finance.yahoo.com/quote/MNMD
- MNMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mnmd
FAQ
What is the ticker symbol for Mind Medicine (MindMed) Inc.?
The ticker symbol for Mind Medicine (MindMed) Inc. is NASDAQ:MNMD
Does Mind Medicine (MindMed) Inc. pay dividends?
No, Mind Medicine (MindMed) Inc. does not pay dividends
What sector is Mind Medicine (MindMed) Inc. in?
Mind Medicine (MindMed) Inc. is in the Healthcare sector
What industry is Mind Medicine (MindMed) Inc. in?
Mind Medicine (MindMed) Inc. is in the Biotechnology industry
What country is Mind Medicine (MindMed) Inc. based in?
Mind Medicine (MindMed) Inc. is headquartered in United States
When did Mind Medicine (MindMed) Inc. go public?
Mind Medicine (MindMed) Inc. initial public offering (IPO) was on November 15, 2016
Is Mind Medicine (MindMed) Inc. in the S&P 500?
No, Mind Medicine (MindMed) Inc. is not included in the S&P 500 index
Is Mind Medicine (MindMed) Inc. in the NASDAQ 100?
No, Mind Medicine (MindMed) Inc. is not included in the NASDAQ 100 index
Is Mind Medicine (MindMed) Inc. in the Dow Jones?
No, Mind Medicine (MindMed) Inc. is not included in the Dow Jones index
When was Mind Medicine (MindMed) Inc. last earnings report?
Mind Medicine (MindMed) Inc.'s most recent earnings report was on November 6, 2025
When does Mind Medicine (MindMed) Inc. report earnings?
The next expected earnings date for Mind Medicine (MindMed) Inc. is March 5, 2026